Tag Archives: IP

Neglected Diseases: What if IP was the Cure?

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

The Lancet Global Health Journal recently published an article “The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment” discussing the current research and development ongoing in this area.  They found 1,500 clinical trials were registered for neglected diseases which represents only 1% of all registered clinical trial activity.  Of the 123 new products in development for neglected disease, more than half were vaccines or biological products.  However, the article points out that Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , ,

South Africa National Policy on Intellectual Property: Inconsistent with Biotech Development Goals

South-African-Flag

BIO submitted comments this week to the government of South Africa on their proposed “Draft National Policy on Intellectual Property.”  Below are some highlights. “BIO and its member companies are aware of the South African government’s aspirations to develop its life sciences industry, a message that South African officials communicated clearly at the recent BIO International Conference in Chicago, USA, in April 2013. At that conference and in subsequent discussions, South African officials have sent Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

New Bill Calls for No WTO-Plus Benefits for Countries that Violate IP

flags with blue sky

A new Bill in the U.S. House of Representatives seeks to remove WTO-plus trade benefits the United States provides to countries that disrespect intellectual property rights.  On September 20, 2013, Representative Terry introduced the “Playing Fair on Trade and Innovation Act.”  The Bill would deem countries ineligible for the Generalized System of Preferences program (GSP) if that country “fails to provide adequate and effective protection for intellectual property rights” or “maintains local content requirements…”  GSP Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

India’s IP Policy: India’s Lead Biotech Innovator Expresses Concern

shutterstock_2103563

Kiran Mazumdar-Shaw, chairperson and managing director of India’s largest biotechnology company Biocon, expressed concern with India’s innovation environment in a recent interview with Livemint.  When asked if the Indian government fosters innovation Ms. Shaw responded: “I am very concerned about the wrong signals we are sending to the world. We have not done anything substantial to build India as a strong global economy. We have wasted a lot of opportunities. We behave like the world Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Joins Alliance for Fair Trade with India

shutterstock_26191726

BIO recently joined the Alliance for Fair Trade with India along with the U.S. Chamber of Commerce, the National Association of Manufacturers, Solar Energy Industries Association, and others. The new Alliance website states: Over the last year, policymakers and courts in India have engaged in a persistent pattern of discrimination that is hurting a wide range of manufacturing and services industries and jobs in the United States. India has recently mandated domestic content rules that Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,